Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose

Blood (2022) 140 (15): 1735–1738.

https://doi.org/10.1182/blood.2022017594

Published: 2022

Includes: Supplemental data

Journal Articles

Three Distinct Groups of Phenotype Severity in Beta-Thalassemia

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-139196

Published: 2020

Journal Articles

COVID 19 and Hemoglobinopathies: Update of the Italian Experience

Irene Motta, MD, Valeria Maria Pinto, MD, Filomena Longo, MD, Federico Bonetti, MD, Elisa De Michele, MD, Alberto Piperno, MD, Lorella Pitrolo, MD, Micol Quaresima, MD, Michela Ribersani, MD, Margherita Migone De Amicis, MD, Manuela Balocco, MD, Barbara Gianesin, PhD, Giovanna Graziadei, MD, Maria Domenica Cappellini, MD, Lucia De Franceschi, MD, Antonio Piga, MD, Gian Luca Forni, MD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-141610

Published: 2020

Journal Articles

Prediction of Cardiac Complications in SCD

Alessia Pepe, MD, Laura Pistoia, Maria Rita Gamberini, MD, Silvia Macchi, MD, Francesca Valeria Commendatore, Elena Facchini, MD, Lorella Pitrolo, Mauro Celli, Aurelio Maggio, MD, Paolo Preziosi, Vincenzo Positano, Antonella Meloni, PhD

Blood (2019) 134 (Supplement_1): 1026.

https://doi.org/10.1182/blood-2019-121843

Published: 2019

Journal Articles

LIC-R2 Values Predict Severity of SCD: Baseline Data from Licnet-S

Rosario Di Maggio, MD, Angela Vitrano, PhD, Carmelo Fidone, MD, Alessandra Quota, MD, Daniela Fiorino, MD, Calogera Gerardi, MD, Saveria Campisi, MD, Lorenzo Tesé, MD, Vincenzo Santoro, MD, Barone Rita, MD, Giangreco Antonino, MD, Paolo Rigano, Lorella Pitrolo, MD, Aurelio Maggio, MD

Blood (2019) 134 (Supplement_1): 4810.

https://doi.org/10.1182/blood-2019-124728

Published: 2019

Journal Articles

Is the Time of Revisiting Classification of Thalassemia Syndromes According with the Phenotype Severity?

Angela Vitrano, PhD, Giuseppina Calvaruso, MD, Lorella Pitrolo, MD, Alessia Pepe, MD, Antonella Meloni, PhD, Laura Pistoia, MD, Maria Rita Gamberini, MD, Vincenzo Caruso, MD, Aldo Filosa, MD, Paolo Ricchi, MD, Liana Cuccia, MD, Domenico D'Ascola, MD, Francesco Sorrentino, MD, Angelo Peluso, MD, Aurelio Maggio, MD

Blood (2017) 130 (Supplement 1): 935.

https://doi.org/10.1182/blood.V130.Suppl_1.935.935

Published: 2017

Journal Articles

Inadequacy of Ferritin Trends for Predicting Changes in LIC Risk Category in Transfusion Depedent and Well Chelated Patients with Haemoglobinopathies

Angela Vitrano, PhD, Massimiliano Sacco, DR, Rosamaria Rosso, MD, Alessandra Quota, MD, Daniela Fiorino, MD, Esther Natalie Oliva, MD, Calogera Gerardi, MD, Gaetano Roccamo, MD, Vincenzo Spadola, MD, Aldo Filosa, MD, Lorenzo Tesé, MD, Giuseppina Calvaruso, MD, Lorella Pitrolo, MD, Laura Mistretta, DR, Filippo Cassarà, DR, Rosario Di Maggio, MD, Aurelio Maggio, MD

Blood (2017) 130 (Supplement 1): 936.

https://doi.org/10.1182/blood.V130.Suppl_1.936.936

Published: 2017

Journal Articles

Lower Levels of LPI in Thalassemia Major Patients Treated with Deferasirox

Alice Pecoraro, DR, Angela Vitrano, PhD, Antonio Troia, DR, Maria Fustaneo, MD, Lorella Pitrolo, MD, Paolo Rigano, MD, Aurelio Maggio, MD, Rosalba Di Marzo, DR

Blood (2016) 128 (22): 4821.

https://doi.org/10.1182/blood.V128.22.4821.4821

Published: 2016

Journal Articles

Survival Comparability Between Thalassemia Major Versus Thalassemia Intermedia

Blood (2015) 126 (23): 2141.

https://doi.org/10.1182/blood.V126.23.2141.2141

Published: 2015

Journal Articles

Congenital Dyserythropoietic Anemias: Molecular Diagnosis and Diagnostic Approach in a Cohort of Italian Patients

Veronica Agrigento, Sclafani Serena, Paolo Rigano, Rita Barone, Giuseppina Calvaruso, Rosario Di Maggio, Massimiliano Sacco, Lorella Pitrolo, Angela Vitrano, Aurelio Maggio, Elena D'Alcamo

Blood (2015) 126 (23): 2142.

https://doi.org/10.1182/blood.V126.23.2142.2142

Published: 2015

Journal Articles

Prospective Changes of Cardiac and Hepatic Iron and Cardiac Function By MR in Pediatric Thalassemia Major Patients Treated with Different Chelators or Not Chelated

Antonella Meloni, PhD, Lorella Pitrolo, MD, Blandina Pagano, MD, Giancarlo Izzi, MD, Augusto Scaccetti, MD, Aurelio Maggio, MD, Maria Giovanna Neri, PhD, Elisabetta Chiodi, MD, Chiara Tudisca, MD, Cristina Salvatori, MSc, Vincenzo Positano, MSc, Alessia Pepe, MD PhD

Blood (2014) 124 (21): 4901.

https://doi.org/10.1182/blood.V124.21.4901.4901

Published: 2014

Journal Articles

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

Blood (2014) 124 (21): 1354.

https://doi.org/10.1182/blood.V124.21.1354.1354

Published: 2014

Journal Articles

The Prognostic Role of Diabetes Mellitus for Cardiac Complications in a Large Cohort of Well Treated Thalassemia Major Patients

Antonella Meloni, PhD, Maria Rita Gamberini, MD, Giuseppe Rossi, MSc, Francesco Sorrentino, MD, Domenico Giuseppe D'Ascola, MD, Anna Spasiano, MD, Aldo Filosa, MD, Liana Cuccia, MD, Nicola Dello Iacono, MD, Gianluca Forni, MD, Vincenzo Caruso, MD, Aurelio Maggio, MD, Lorella Pitrolo, MD, Angelo Peluso, MD, Massimo Midiri, MD, Massimiliano Missere, MD, Maria Giovanna Neri, PhD, Alessia Pepe, MD PhD

Blood (2014) 124 (21): 4043.

https://doi.org/10.1182/blood.V124.21.4043.4043

Published: 2014

Journal Articles

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Blood (2011) 118 (21): 3197.

https://doi.org/10.1182/blood.V118.21.3197.3197

Published: 2011

Journal Articles

Prospective Comparison on Cardiac and Hepatic Iron and Cardiac Function by MR in Thalassemia Major Patients Treated with Combination Deferiprone–Desferrioxamine Versus Deferiprone and Desferrioxamine in Monoterapy,

Alessia Pepe, Antonella Meloni, PhD, Pasquale Pepe, Marcello Capra, M.D., Domenico Giuseppe D'Ascola, Michele Santodirocco, Paolo Cianciulli, M.D., Vincenzo Caruso, M.D., Maria Antonietta Romeo, M.D., Aldo Filosa, Lorella Pitrolo, Maria Caterina Putti, MD, Aurelio Maggio, MD, Massimiliano Missere, Vincenzo Positano, Massimo Lombardi, Paolo Ricchi

Blood (2011) 118 (21): 3194.

https://doi.org/10.1182/blood.V118.21.3194.3194

Published: 2011

Journal Articles

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Blood (2011) 118 (21): 5302.

https://doi.org/10.1182/blood.V118.21.5302.5302

Published: 2011

Journal Articles

Prospective Comparison on Cardiac Iron and Liver Iron by MR In Thalassemia Major Patients Treated with Combination Deferipron–Desferrioxamine Versus Deferipron and Desferrioxamine In Monoterapy

Alessia Pepe, Giuseppe Rossi, Antonella Meloni, Dell'Amico Maria Chiara, Marcello Capra, incenzo Caruso, V, Lorella Pitrolo, MD, Michele Centra, Pasquale Pepe, Eliana Cracolici, Lucia De Franceschi, MD, Massimo Lombardi, Paolo Ricchi

Blood (2010) 116 (21): 5164.

https://doi.org/10.1182/blood.V116.21.5164.5164

Published: 2010

Journal Articles

Neridronate (NE) for the Treatment of Osteoporosis In Patients with β-Thalassemia: Results from an Italian Multicenter Randomized, Open Label, Phase II Trial

Gian Luca Forni, MD, Silverio Perrotta, MD, Caterina Borgna Pignatti, MD, Domenico Giuseppe D'Ascola, MD, Bruno Nobili, MD, Lorella Pitrolo, MD, Giovanni Quarta, MD, Paolo Rigano, MD, Laura Zanaboni, MD, Ernesto Palummeri, MD

Blood (2010) 116 (21): 4282.

https://doi.org/10.1182/blood.V116.21.4282.4282

Published: 2010

Journal Articles

Cardiac and Liver Magnetic Resonance Characterization of Thalassemia Intermedia Patients: A Comparative Multicenter Study Versus Thalassemia Major Patients

Alessia Pepe, MD, PhD, Brunella Favilli, MSc, Anna Ramazzotti, PhD, Vincenzo Positano, MSc, Caterina Borgna-Pignatti, MD, Marcello Capra, MD, Maria-Eliana Lai, MD, Anna Spasiano, MD, Lorella Pitrolo, MD, Aldo Filosa, MD, Paolo Cianciulli, MD, Antonietta Mascolino, MD, Gaetano Giuffrida, MD, Gianluca Forni, MD, Aurelio Maggio, MD, Massimo Lombardi

Blood (2008) 112 (11): 5421.

https://doi.org/10.1182/blood.V112.11.5421.5421

Published: 2008

Journal Articles

Comparison of Deferasirox, Deferiprone, and Desferrioxamine Effectiveness on Myocardial Iron Concentrations and Biventricular Function by Quantitative MR in Beta-Thalassemia Major

Blood (2008) 112 (11): 3872.

https://doi.org/10.1182/blood.V112.11.3872.3872

Published: 2008

NARROW

Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose

Three Distinct Groups of Phenotype Severity in Beta-Thalassemia

COVID 19 and Hemoglobinopathies: Update of the Italian Experience

Prediction of Cardiac Complications in SCD

LIC-R2 Values Predict Severity of SCD: Baseline Data from Licnet-S

Is the Time of Revisiting Classification of Thalassemia Syndromes According with the Phenotype Severity?

Inadequacy of Ferritin Trends for Predicting Changes in LIC Risk Category in Transfusion Depedent and Well Chelated Patients with Haemoglobinopathies

Lower Levels of LPI in Thalassemia Major Patients Treated with Deferasirox

Survival Comparability Between Thalassemia Major Versus Thalassemia Intermedia

Congenital Dyserythropoietic Anemias: Molecular Diagnosis and Diagnostic Approach in a Cohort of Italian Patients

Prospective Changes of Cardiac and Hepatic Iron and Cardiac Function By MR in Pediatric Thalassemia Major Patients Treated with Different Chelators or Not Chelated

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

The Prognostic Role of Diabetes Mellitus for Cardiac Complications in a Large Cohort of Well Treated Thalassemia Major Patients

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Prospective Comparison on Cardiac and Hepatic Iron and Cardiac Function by MR in Thalassemia Major Patients Treated with Combination Deferiprone–Desferrioxamine Versus Deferiprone and Desferrioxamine in Monoterapy,

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Prospective Comparison on Cardiac Iron and Liver Iron by MR In Thalassemia Major Patients Treated with Combination Deferipron–Desferrioxamine Versus Deferipron and Desferrioxamine In Monoterapy

Neridronate (NE) for the Treatment of Osteoporosis In Patients with β-Thalassemia: Results from an Italian Multicenter Randomized, Open Label, Phase II Trial

Cardiac and Liver Magnetic Resonance Characterization of Thalassemia Intermedia Patients: A Comparative Multicenter Study Versus Thalassemia Major Patients

Comparison of Deferasirox, Deferiprone, and Desferrioxamine Effectiveness on Myocardial Iron Concentrations and Biventricular Function by Quantitative MR in Beta-Thalassemia Major

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only